Introduce

Business introduction

MISSION

VRIC aims to identify unmet medical needs for infectious disease vaccines and biomarkers and conduct translational research through a multi-center/multidisciplinary platform.

  • Functioning as the central laboratory for clinical trials and collaborating with international organizations

  • Ensuring self-sufficiency and globalization of domestic vaccines and expanding the role of the Ministry of Food and Drug Safety clinical trial specimen analysis institute

  • Providing and serving as a focal point for infectious disease-related industry, academia, hospitals, and research-associated platform

  • Bacterial, fungal, and viral domestic molecular epidemiology and pathogenesis

  • Developing early diagnostic systems using biomarkers and conducting research on source technologies for treatment

  • Leading the clinical application and commercialization of the cutting edge diagnostic and therapeutic technologies for infectious diseases, including advanced regenerative medicine

Vaccine-Bio Research Institute,
Catholic University of Korea (VRIC)

  • Vaccine technology development (self-sufficiency)
    and vaccine standardization projects
  • Designing clinical trials
    Vaccine development and evaluation, diagnostic biomarker and infectious disease therapeutic clinical trials
  • Rich infectious disease-based clinical experience
    Early identification of unmet medical needs
  • Research on industrialization of infectious disease response technology and the development of biomarkers and diagnostic kits
  • Analyzing clinical trial samples
    Evaluating clinical validity and performance of developed vaccines and diagnostic biomarkers (immunogenicity, sensitivity, specificity, etc.)
  • Multilateral (global) collaboration-based infectious disease response technology development platform
    Establishing global partnerships to develop medical technologies for unmet medical needs in collaboration with other research organizations, such as the International Vaccine Institute
GCP - Good Clinical Practice, GCLP - Good Clinical Laboratory Practice GCP - Good Clinical Practice, GCLP - Good Clinical Laboratory Practice
VRIC - Vaccine Bio Research Institute, the Catholic University of Korea

Designing clinical trial technologies

Accumulating skills in clinically-based translational research
  • Experience in infectious disease clinical and non-clinical research (new drugs, vaccines, etc.)
  • Accumulating clinical information on infectious diseases
  • Reflecting the needs of the field (bottom-up)
Infectious disease response technology platform
  • Network-based labor pool of infection specialists
  • Emerging/variant pathogen analysis
  • Antimicrobial resistance (AMR) research
  • Resistance and virulence gene analysis

Clinical basic translational research

GCLP for vaccine standardization/vaccine
  • Clinical research collaborations
  • Evaluating vaccine efficacy in development
  • GCLP designated by the Ministry of Food and Drug Safety
  • Central lab of the International Vaccine Institute
Developing clinically relevant biomarkers
  • Developing diagnostic and therapeutic biomarkers
  • Development projects in collaboration with institutions such as POSTECH, KAIST, KIST, etc.
  • Providing a clinical simulation environment for diagnostic technology development
  • Clinical evaluation of developed diagnostic technologies

Building a support system for vaccine development, evaluation, and clinical trials
(2011-present, 42 projects, KRW 12,237,000,000)

  • Vaccine-based technology and standardization (GLP)
  • Clinical trial evaluation infrastructure for the developed vaccine (GCLP)​
  • Vaccine standardization projects
    • International standardization development research
    • Non-clinical models for evaluating vaccine technologies
    • Standardizing immunogenicity evaluation methods
  • Evaluating vaccine clinical trials
    • Analyzing clinical trials of locally developed vaccines
    • Developing and evaluating clinical trial immunogenicity assay protocols
  • Building a support system for clinical trials
    • Multicenter clinical trial Infrastructure
    • Clinical support for new vaccine development
    • Accelerating development of new infectious disease drugs

Infectious disease-based research and biomarker development
(2011-present, 48 projects totaling KRW 4,394,222,000)

  • Providing a clinical simulation environment for biomarker development
  • Clinical evaluation of developed diagnostic technologies​
  • Basic research and evaluation sample development
    • Infectious disease basic research
    • Development system management substances
    • SL 2/3 qualitative/quantitative control group
    • Clinical specimen utilization simulation
  • Clinically relevant biomarker validation technologies
    • Biomarker validation clinical specimen collection
    • Biomarker clinical protocol development
  • Evaluating development system clinical trials
    • Analytic performance evaluation
    • Validating comparative correlation
    • Develop biomarker-enabled diagnostic and treatment algorithms
Clinically-based collaborative networks
  • Infectious diseases (8 CMC hospitals)
  • Laboratory medicine
  • Hematology
  • Respiratory medicine
External cooperation research institutes and government-contributed agencies
  • International Vaccine Institute, under the WHO
  • Ministry of Food and Korea Disease Control and Prevention Agency
  • Korea Health Industry Development Institute, National Research Foundation,
    pan-ministerial full cycle research initiatives, etc.
Research collaborations with other universities, and pharmaceutical and diagnostic companies

Research collaborations

  • KAIST, KIST
  • POSTECH, Korea University
  • Kwangwoon University, Chungnam National University, etc.
Basic medical sciences laboratories and research institutes
  • Microbiology lab
  • Pharmacology lab
  • Biochemistry lab
Diagnosis and treatment
  • Lucas Bio
  • Connectagen
  • Pepxgen
Vaccine-Bio Research Institute, Catholic University of Korea NOW Vaccine-Bio Research Institute, Catholic University of Korea NOW Vaccine-Bio Research Institute, Catholic University of Korea NOW